An organization that supports 145 guests and their families each year through its two residences has announced a rebranding ...

Imbuing his work with a volatile mix of tenderness, aggression, sophistication, and obscenity, the Roman poet left a record ...

Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...

Life Insurance Corporation of India (LIC) has clarified recent media reports suggesting its entry into the health insurance sector. The corporation stated that it is in advanced discussions to ...

Zydus Lifesciences Ltd. has received final nod from the United States Food and Drug Administration to manufacture 60 mg Apalutamide tablets, according to an exchange filing on Tuesday. Apalutamide is ...

Speaking to the media, the Odisha Governor emphasized that Debendra Pradhan was a man who remained stuck to his ideology throughout his life. "Devendra Pradhan was a man dedicated to an ideology ...

Zydus Life share price: Pharmaceutical company Zydus Lifesciences shares were in demand on Monday, March 17, 2025, as the scrip popped 1.90 per cent in early trade to hit an intraday high of Rs 899.40 ...

We know that YouTube is becoming a new home for podcasts, but to help expand, the dedicated Android TV apps dedicated “Podcasts” sidebar tab is now rolling out widely. We’re not quite sure ...

CALGARY, Alberta, March 13, 2025 (GLOBE NEWSWIRE) -- On March 26, the National Music Centre (NMC) will unveil a new exhibition at Studio Bell, in partnership with The Canadian Academy of Recording ...

Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus ...

Zydus Lifesciences, one of India's leading drugmakers ... Managing Director with consulting firm Alvarez and Marsal's Healthcare and Life Sciences practice in Mumbai. "So, looking at newer ...

The acquisition aims to boost Zydus's global medtech ambitions, leveraging its expertise in life sciences. The deal includes a 81% premium over Amplitude Surgical's last closing price, aiming for ...